New Alzheimer's drug: What to know as Leqembi hits the market
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
Stay updated with breaking news from Sam Gandy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Here are some things to know about the FDA's approval of lecanemab, to be sold under the brand name Leqembi.
Preliminary results offer hope that gene therapy can protect people with a version of the brain disease driven by a particular gene variant.
The drug, lecanemab also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.
/PRNewswire/ -- A change in the DNA code (mutation) of a gene that plays a key role in the brain's immune defenses may prevent related cells from clearing away...